Fig. 2From: The first nationwide multicenter study of Acinetobacter baumannii recovered in Serbia: emergence of OXA-72, OXA-23 and NDM-1-producing isolatesAntimicrobial resistance of A. baumannii in different hospital wards. AMS â ampicillin-sulbactam; TZP - piperacillin-tazobactam; CAZ - ceftazidime; FEP - cefepime; MER - meropenem; IMP - imipenem; GEN - gentamicin; AK - amikacin; TOB - tobramycin; TET - tetracycline; CIP - ciprofloxacin; LEV - levofloxacin; TSX - trimethoprim-sulfamethoxazole; COL - colistin; TYG - tigecycline.*PÂ <â0.05Back to article page